Given the efficacy of chemerin-mediated anti-tumor responses seen now in several tumor settings, future research investigating chemerin's roles in additional tumor types is warranted, with a particular focus on manifesting its therapeutic potential for cancer treatment. This evidence concerns the gene RARRES2 and cancer.